Hot Issues
Take action!
Contact your legislators to stop fake online pharmacies and report social media drug sellers to the DEA
Follow us: Twitter | YouTube | Facebook | LinkedIn | Instagram
Researchers have found pentobarbital in counterfeit prescription pills. Plus, domestic and international news, and what our executive director is reading this week.
This is a reprint of an FDA Alert. Boulla LLC Issues Voluntary Nationwide Recall of Boom Max Capsules Due to the Potential Presence of Undeclared Sildenafil When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or…
A whistleblower complaint alleges that counterfeit and misbranded diabetes medical devices were being sold by third-party vendor on Amazon and orders were fulfilled by Amazon.com itself.
A new lawsuit says that another ring has been selling counterfeit HIV medicine in the U.S. Eli Lilly is taking action against compounders selling tirzepatide. More domestic and international news.
A New York couple admitted to selling sildenafil in supplements they claimed were “all-natural.” Ethiopian researchers say that one-fifth of medicines in African are fake or substandard. Additional news in Canada, the U.K, Thailand and Kurdistan.
A white paper examines how to detect and respond to substandard and fake medicine. A small study shows why buying semaglutide on line is dangerous. Police in Ukraine busted a counterfeit medicine drug ring. These stories and more in this week’s news.
Our podcast covers the latest in pharma crime and medicine safety.
Like your information on video? Subscribe to our YouTube playlist!
Are your injected diabetes and weight-loss meds safe? Watch.
The CAST Act would make counterfeiting controlled substance pills a federal crime. Learn why that's important.
What in this year's DEA National Drug Threat Assessment? Find out here.
Click the images below to see more recent videos.